You are here

immunology

J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups

Fierce Pharma

Fri, 10/25/24 - 11:43 am

plaque psoriasis

atopic dermatits

GSK becomes Flagship's latest partner in $7B biobucks respiratory, immunology pact

Fierce Biotech

Mon, 07/29/24 - 11:03 am

Flagship Pioneering

Where competition is heating up in pharma

Pharma Voice

Fri, 05/24/24 - 11:06 am

ulcerative colitis

Moderna Therapeutics

AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J

BioSpace

Mon, 04/22/24 - 11:45 am

IGM and Sanofi collaboration will pivot to immunology and inflammation

Pharmaceutical Technology

Wed, 04/17/24 - 10:09 pm

IGM Biosciences

AbbVie wraps up $64M oncology, immunology deal with Tentarix

Fierce Biotech

Thu, 02/22/24 - 11:28 am

Foundery, a new biotech venture firm, sets out to speed early immune drug research

BioPharma Dive

Tue, 08/22/23 - 09:42 am

venture capital

Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study

Marketwatch

Tue, 05/23/23 - 10:12 am

autoimmune disease

2 Things About AbbVie That Investors Are Ignoring

Motley Fool

Wed, 05/3/23 - 10:34 pm

Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas

BioSpace

Wed, 04/26/23 - 10:24 am

cardiovascular disease

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

Merck’s latest deal turns up the spotlight on immune system drugmakers

BioPharma Dive

Mon, 04/17/23 - 10:47 pm

Prometheus Biosciences

Argenx, Genmab pool expertise on antibody discovery, joining forces to expand into new therapeutic areas

Fierce Biotech

Mon, 04/17/23 - 11:19 am

antibody discovery

IPO Market Shows Signs of Life as Acelyrin Begins Nasdaq Bid

BioSpace

Sun, 04/16/23 - 11:10 pm

AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets

Fierce Biotech

Tue, 01/10/23 - 11:05 am

small molecule drugs

undruggable targets

Biosimilars hit a turning point as they expand outside oncology

Clinical Trials Arena

Fri, 12/9/22 - 10:31 am

gastroenterology

metabolic disorders

musculoskeletal disorders

10 months after first mega round, Glick's Odyssey raises $168M to gear up for entering clinic

Fierce Biotech

Thu, 10/13/22 - 09:18 am

Odyssey Therapeutics

venture capital

immuno-oncology

Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light

Fierce Pharma

Thu, 05/19/22 - 12:05 pm

BMS joins Octant’s $80M financing and signs on as a drug discovery partner

MedCity News

Thu, 04/21/22 - 11:14 pm

Bristol Myers Squibb

Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab

BioSpace

Tue, 03/29/22 - 10:53 am

IGM Biosciences

Pages